Treatment for eating disorders : 5
Transcription
Treatment for eating disorders : 5
Treatment for eating disorders : 5-HT4 receptors TECHNICAL DESCRIPTION Our reference : 85584-01 Status des brevets French patent application FR0213725 filed on October 31, 2002 and entitled "Composition pharmaceutique pour la préparation d'un médicament destiné à traiter et/ou prévenir une pathologie liée à une conduite obsessionnelle" Inventors Valérie COMPAN Status Commercial Exclusive or nonexclusive licenses and collaborative research. Laboratoires Centre CNRS-INSERM de Pharmacologie- The invention describes the role of 5-HT4 receptors. The inventors have performed tests in mice and have shown that inactivation of the 5-HT4 receptors helps to a decrease sensitivity to stress-induced anorexia. INDUSTRIAL APPLICATIONS 5-HT4 receptor antagonists could be used to treat Anorexia and decrease sensitivity to drug abuse. Moreover, 5-HT4 receptor agonists could be used to treat bulimia and hyperphagia. Endocrinologie (CCIPE, UPR9023), Montpellier, France. Keywords : Eating disorders Addiction, 5-HT4 receptors Powered by TCPDF (www.tcpdf.org)